Investigator-led Trials Groups
These groups conduct world-class multi-disciplinary research for disease control. Clinical trials help to inform clinical practice and improve the survival and quality of life of patients living with a lung disease.
Australasian Lung Cancer Trials Group
The Australasian Lung Cancer Trials Group (ALTG) is Australia and New Zealand’s lung and thoracic cancer clinical research group. Lung Foundation Australia launched ALTG in 2004 and is a multi-disciplinary trials group dedicated to reducing the incidence, morbidity and mortality of lung and other thoracic cancers and improving the quality of life of these patients, carers and families in Australia and New Zealand through the coordination and facilitation of high quality clinical research.
The ALTG collaborates with a number of organisations including the NHMRC Clinical Trials Centre (CTC) and Peter MacCallum Cancer Centre. Both of these groups are leaders in Australia for the design, conduct, analysis and publication of oncology clinical trials, including working with both Australia and international collaborative groups.
For more information visit the website here.
If you are a patient or family member and would like to understand more about participating in investigator-led clinical trials click here.
Thoracic Alliance for Cancer Trials
The Thoracic Alliance for Cancer Trials (TACT) is a unique collaboration of lung cancer research groups enabling lung cancer researchers worldwide to work together to run clinical trials. The collaboration has 13 member groups from across the USA, Europe and Australasia and four international companies supporting the group. TACT Secretariat support is provided by Lung Foundation Australia and was initiated by a group of key investigators together with the Lung Foundation.
For more information visit the website click here.